Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Adaptive Biotechnologies Corp (ADPT) vs Amylx Pharmaceuticals Inc (AMLX) Price & Performance

Adaptive Biotechnologies CorpTrade
Amylx Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Adaptive Biotechnologies Corp vs Amylx Pharmaceuticals Inc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B). The key difference: Adaptive Biotechnologies Corp is the larger of the two by market cap. Which is the better fit depends on your goals.

ADPTAMLX
Market Cap
$4.04B$2.64B
Sector
HealthHealth
52-Week High
$25.45$24.19
52-Week Low
$12.30$7.82
Enterprise Value
$4.10B$2.39B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.

Read more on ADPT

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.

Read more on AMLX